AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines

The utility of AsCas12a can be limited to poor editing efficiency. Here the authors identify a variant, “AsCas12a Ultra”, that has high on-target specificity demonstrated through editing of clinically relevant T cell genes.

Guardado en:

Detalles Bibliográficos
Autores principales:	Liyang Zhang, John A. Zuris, Ramya Viswanathan, Jasmine N. Edelstein, Rolf Turk, Bernice Thommandru, H. Tomas Rube, Steve E. Glenn, Michael A. Collingwood, Nicole M. Bode, Sarah F. Beaudoin, Swarali Lele, Sean N. Scott, Kevin M. Wasko, Steven Sexton, Christopher M. Borges, Mollie S. Schubert, Gavin L. Kurgan, Matthew S. McNeill, Cecilia A. Fernandez, Vic E. Myer, Richard A. Morgan, Mark A. Behlke, Christopher A. Vakulskas
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/0168163683a24415a8a5f32e5a19e09a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0168163683a24415a8a5f32e5a19e09a
record_format	dspace
spelling	oai:doaj.org-article:0168163683a24415a8a5f32e5a19e09a2021-12-02T18:02:47ZAsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines10.1038/s41467-021-24017-82041-1723https://doaj.org/article/0168163683a24415a8a5f32e5a19e09a2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-24017-8https://doaj.org/toc/2041-1723The utility of AsCas12a can be limited to poor editing efficiency. Here the authors identify a variant, “AsCas12a Ultra”, that has high on-target specificity demonstrated through editing of clinically relevant T cell genes.Liyang ZhangJohn A. ZurisRamya ViswanathanJasmine N. EdelsteinRolf TurkBernice ThommandruH. Tomas RubeSteve E. GlennMichael A. CollingwoodNicole M. BodeSarah F. BeaudoinSwarali LeleSean N. ScottKevin M. WaskoSteven SextonChristopher M. BorgesMollie S. SchubertGavin L. KurganMatthew S. McNeillCecilia A. FernandezVic E. MyerRichard A. MorganMark A. BehlkeChristopher A. VakulskasNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Liyang Zhang John A. Zuris Ramya Viswanathan Jasmine N. Edelstein Rolf Turk Bernice Thommandru H. Tomas Rube Steve E. Glenn Michael A. Collingwood Nicole M. Bode Sarah F. Beaudoin Swarali Lele Sean N. Scott Kevin M. Wasko Steven Sexton Christopher M. Borges Mollie S. Schubert Gavin L. Kurgan Matthew S. McNeill Cecilia A. Fernandez Vic E. Myer Richard A. Morgan Mark A. Behlke Christopher A. Vakulskas AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
description	The utility of AsCas12a can be limited to poor editing efficiency. Here the authors identify a variant, “AsCas12a Ultra”, that has high on-target specificity demonstrated through editing of clinically relevant T cell genes.
format	article
author	Liyang Zhang John A. Zuris Ramya Viswanathan Jasmine N. Edelstein Rolf Turk Bernice Thommandru H. Tomas Rube Steve E. Glenn Michael A. Collingwood Nicole M. Bode Sarah F. Beaudoin Swarali Lele Sean N. Scott Kevin M. Wasko Steven Sexton Christopher M. Borges Mollie S. Schubert Gavin L. Kurgan Matthew S. McNeill Cecilia A. Fernandez Vic E. Myer Richard A. Morgan Mark A. Behlke Christopher A. Vakulskas
author_facet	Liyang Zhang John A. Zuris Ramya Viswanathan Jasmine N. Edelstein Rolf Turk Bernice Thommandru H. Tomas Rube Steve E. Glenn Michael A. Collingwood Nicole M. Bode Sarah F. Beaudoin Swarali Lele Sean N. Scott Kevin M. Wasko Steven Sexton Christopher M. Borges Mollie S. Schubert Gavin L. Kurgan Matthew S. McNeill Cecilia A. Fernandez Vic E. Myer Richard A. Morgan Mark A. Behlke Christopher A. Vakulskas
author_sort	Liyang Zhang
title	AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
title_short	AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
title_full	AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
title_fullStr	AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
title_full_unstemmed	AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
title_sort	ascas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/0168163683a24415a8a5f32e5a19e09a
work_keys_str_mv	AT liyangzhang ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT johnazuris ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT ramyaviswanathan ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT jasminenedelstein ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT rolfturk ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT bernicethommandru ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT htomasrube ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT steveeglenn ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT michaelacollingwood ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT nicolembode ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT sarahfbeaudoin ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT swaralilele ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT seannscott ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT kevinmwasko ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT stevensexton ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT christophermborges ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT molliesschubert ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT gavinlkurgan ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT matthewsmcneill ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT ceciliaafernandez ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT vicemyer ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT richardamorgan ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT markabehlke ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines AT christopheravakulskas ascas12aultranucleasefacilitatestherapidgenerationoftherapeuticcellmedicines
_version_	1718378847708119040

AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines

Ejemplares similares